MedTrace Logo

Ultrasound Assisted Wound Debridement (UAW) Versus Standard Wound Treatment in Complicated Diabetic Foot Ulcers (DFU)

NCT04633642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2021-07-14

Study results available
· View outcomes & findings →

Summary

The investigators aimed to elucidate the effects of UAW debridement on cellular proliferation and dermal repair in complicated diabetic foot ulcers as compared to diabetic foot ulcers receiving surgical/sharp wound debridement. A randomized controlled trial was performed involving outpatients with complicated diabetic foot ulcers that either received surgical debridement or UAW debridement every week during a six-week treatment period.

Conditions

  • Diabetic Foot Ulcer

Interventions

PROCEDURE

Ultrasound group

Every week during a six-week treatment period

PROCEDURE

Surgical group

Every week during a six-week treatment period

Sponsors & Collaborators

  • Francisco Javier Álvaro Afonso

    collaborator UNKNOWN

  • David Sevillano Fernández

    collaborator UNKNOWN

  • Yolanda García Álvarez

    collaborator UNKNOWN

  • Irene Sanz Corbalan

    collaborator UNKNOWN

  • Esther García Morales

    collaborator UNKNOWN

  • Universidad Complutense de Madrid

    lead OTHER

Principal Investigators

  • Lázaro Martinez, Professor · Universidad Complutense de Madrid

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-11-01
Completion
2019-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04633642 on ClinicalTrials.gov